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Improved hypercalcemia after
debulking of Uremic Tumoral Calcinosis
in a parathyroidectomized patient
This paper was presented at the
2004 Annual Scientific Meeting of
the Hawaii Chapter ot American
College of Physicians. The Hawaii
Medical Journal published a two
part series of papers presented at
the annual meeting in the Septem
ber and November 2004 issues.
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Abstract
firomic TumoraiCaicinosis (UT is a rare comphcatror
ofchronic kidneydisease on dialysis, charactenhedbv
large periarticular calcification. Among some noses,
hypercalcemia with no conventional etiologies has
been reported. We present a case of UTC in which
hypercaicemia occurredafterparathyroidectomyand
introduction of/ow-calcium containing dia/ysate. Work-
up of hypercalcemia did not re veal any conventional
etiology but hyoercalcemia resolved after debuiking
of the tumor This change in serum calcium gives
us an insight into the mechanism of hypercalcemia.
occasionally seen among cases with UTC.
Introduction
FTC is a complication of chronic kidney disease on
dialysis. Its prevalence appears to have increased
recently Although histologically benign. FTC is
generally progressive. may result in significant pain.
i mniobilization. skin ulceration’. secondar infection
and e en death’h The pathouenesis of FTC is not
uI Iv understood Among some cases. h\ percalcemia
ith no conventional etioioeies has been reported. It
is h\pothesized. in those cases, that FTC can he an
endogenous suppls of calcium. mobilizing calcium
into serum. To our knowledge, our case is the line
report in the English literature to describe post—exci-
sional improvement of hvpercalceniia in FTC.
We review the literature regarding the palhogenesis
of FTC. its association with hvpercalcemia. and
treatment.
Case Report
ear—old multiethnic—Ha w’auan woman began
pertoneal dial’ sis in 1993 because of proeresslon
of idiopathic elomerulonephritis. She rece\ ed a
li ing—related renal transplant in I 997. Hoes e ci. she
suffered a rejection in 1999. and subsequentl started
on heniodial As 3hr3Omin Dialysate: Ca 2.5mEq!L.
K 2iimEq/L Dialyzer MCA 160, Blood Flos’ Rate
350cclminutej with the (Allowing medications: cal
cium carbonate ig =400mg of elemental calcium)
orally. 3 times a day, calcitriol I meg intravenousl -
3 limes a week on each ED, (subsequently switched
to or ul form) Epogen If) 000 units suheutanLoush
times a week on each HI). Three days after, laboratory
data were as follows: total calcium (Ca) 7.5 mg/dL,
phosphate (P)7.4mg!dL, albumin 3.5 g/dL.
She was discovered to have a large calcified mass
around the right hip in December 2001 (Figure 1) but
refused further evaluation. The laboratory results
one month prior were as follows: intact parathyroid
hormone (iPTH) 390pg!mL (reference range 12.6-
53.Spg/rnU. K 5.9mEq/L, Cl 96mEq/L, HCOr 2OmEq/
L BEN 92mg/dL, Cr lO.2mg/dL, Ca 10.1 mg/dL, P
7.3mg/dL, albumin 3.8 gIdL. alkaline phosphatase
(ALK-P) 147 U/L (reference range 39-I l7U/L).
Because of increased CaxP product, calcitriol was
discontinued, and calcium carbonate was switched to
sevelainer 800mg. orally, 3 times a day. Diet restric
tion. especially phosphate restriction was discussed.
Repeat renal transplantation was suggested to the
patient as an option, but she was reluctant because
of her pre’ious reaction to steroids (i.e. palpitations.
and demonic dreams). She was not always compli
ant to medications and diet restriction. As a result.
her indices for sec ondarv hvperparathvroidism did
not improve as represented in the following: i P’l’H
306 pv/mL. Ca 9.2 mg/dL. P 7.$nig!clL in December
2002.
Her pain around the right hip ‘Jowly progressed to
the point where she opted for total pai-athvroidectoniv
in an attempt to obtain s’ mptomatic relief. Despite
the operation performed in February 2003. her pre
dials ‘Js serum calcium level remained high: Ca II .0
mg/dl.. P X.4mg/dL. albumin 3.1 g/dL. ALK—P 17,3
[IL. Therefore. beginning Feb..i-tr’ 2003. calcium
concentratIon ofdialvsate xsas loss eredfrom 2.5mEq/I.
to 7.UniEq/’L. 3hr 30mm. Dial’sate: Ca 2.OmEq/L.
1.)ial icr F70\R. Blood Flow Rate 400cciminute
Hoss es ci. the Inass reniained unchanged. and herserum
calcium appeared to es en increase to 11.0 mg/dL.
.\t that point, an extensive workup was completed
for her hvpercalcernia. The results, including serum
s itamin I) levels, parathyroidhormonerelated peptide.
serum protein electrophoresis and hone scan. were
unrevealing I TahleI). Hypercalcemia appeared to he
due to mobilization of calcium from the large ealci
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lied mass. Serum calcium levels taken from different
venous sites laded todemonstrate differences between
the sites Table I
In June 2003 the patient presented with a complaint
of rght hi p pain after a f’al I and ss as subsequently ad
muted for pain control. MRI showed a 27x 4x 17 cm
calcified mass with fluid—filled loculations. which is
characteristic for LTC’, in the soft tissues of the right
hip and proximal femur (Ficures 2. 3, Compared to
the pres ious film in 2001. the mass was essentiall\
unchanged. The patient continued to have intractable
pain refractory to opioids. She elected to undergo an
excision of the mass because of the pain. Pre-operative
core needle biopsy showed calcification and benign
soft tissue fragments with no evidence of neoplasm.
In J ulv 2003. excision and debulking of the mass
was performed. Because of too much intermingline of’
the soft tissue with the mass, a clean dissection could
not he performed. Histological findings showed calci
fication’. surrounded by libro—fattv tissue and skeletal
muscle withotit es idence of neoplasm. Eleven days
after the surger the patient was discharged in good
cond it i OiL
Twenty-three days after the surgery, however, the
patient presented with fever, chills and increased pain
at the surgical site. Foul-smelling, purulent material
was draining from the incision site. She was admitted
and intravenous antibiotics were started. Her regular
medications were not changed. DcThridements of the
right thigh were carried oul on multiple occasions
because of non—healing wound infection. Wound
cultures a’rew Pmreitv mirabth.s and Enlemcouciis
species. Despite vigorous treatment, her svound
never healed. On post—operative day #67. she died
from sudden cardiopulmonary arrest
. .-\utops\ was
not performed. Her post-operative calcium levels
had dropped l’rom I 0.Xmg/dL (post-operative #1) to
8.Smg/di. (post-operative #34L Her serum albumin
levels remained stable 2.9g/dL(post-operative day#8),
32g/dL(post-operative #23). 3.2g/dL(post-operative
#65).
Discussion
Tumoral calcinosis ) TC ii characterited h\ massive
calcium—phosphate deposits. usuall periarticular
in location. The etioloev ma\ be divided into tw i
cateL’ories: prunarv and secondar
- Primary TC i’.
postulated to he an autocoinal recessive disorder
Secondar\ TC. known as ureinic TC ) [TC. is well
recognized in patients vs ith chronic kidney disease
on dialsis.
The exact pathogenesis of [TC is not fully uu
derstood, The following factors are associated with
UTC-’’: I tincreased calcium-phosphate product
(CaxP), 2i mpaired mineralization of the hone (renal
osteod stroph ) .3)secondary h\ perparathyroidism.
4)aluminuin overload, 5) local factors, such as tissue
Cosyntropin Stimulaton Test
Serum Cortisol levels
mco:dLi
Tablel — Findings on Workup for Hynercalcemia
Reset Reference Range
Ca img/dU 13 8.4-10.2
Phos imge’dLt 5.6 2.6-5.4
Albume udL 3.5 3.5-5.0
VtamnD (25-OH ngmLi <5 20-57
ViraminD (1,25(OH2 pc.rnL) 9 15-75
serum Aluminum rncgL;r 6 <30
PTHrP (pmol/L) 0.7 <1.3
intact PTH (pg/mL) <1 7-53
21.3 baselinel
28.5 30mim
2-24
27,5 (60mim
Serum Ca levels from the different sites
mg!dLi
Right antecubital vein
Right femoral vern
Left temoral vein
11.3
11.3
8.4-10.2
11.6
8.4-10.2
8.4-10.2
Serum Protein Electrophoresis: Normal
Bone scan No tumor
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Figures 23.— MRI showed a calcified mass with fIud filled loculations in the soft tissues of the right hip
and proximal femur.
injury, hematoma, infection, and injection. There are
recent cases lacking evidence of hyperparathyroid
ism Therefore. many authors considcr increased
CaxP to he the most iniportant predisposing factor for
recent cases of ETC.
The prevalence of ETC appears to have increased
to 3 in I NU-972 1mm 1) .)i in the period of 1968-
I 98ii’. Some authors speculate that this increase max
be due to increased use of calcium—based phosphorus
hinders and vitamin D, and long—term use ofdialysate
with relatively high Ca concentration, all of which
could result in positive calcium balanceU
Hypercalcernia is freqLientlv observed in ETC5 7
As in our case. hypercalcemia in sonic ETC cases
cannot be attributed to conventional enologics such
as hvperparathvroidism. excess of vitamin D. ma—
lignancv. or granulomatous diseases. It appears that
ETC itself can cause lix pcrcalceniia independent
of parathx roid hormone. or ‘ itamin D status. The
postulated mechanism is increased release of calcium
from UTC in the presence of adynaniic bone disease.
in whichcondition mineralization of calcium intobone
is impaired . This hypothesis is supported by the
following facts: I) Animal models demonstrated that
calcium resorption from soft tissuecalcificationcauses
significant lix percalcenna in parathsroidectomized
rats with normal and abnormal renal fnnction-. 2
Transient increase in serum calcium and phosphate2
as well as urinarx excretion ofcalcium and phosphate.
during regressions ofEiC in cases on dialx sis or with
renal transplants .3) Induction of a negative calcium
balance appears to further facilitate mobilization of
calcium from UTC 2 Interestingly, it appears that the
more aggressively a negative balance of calcium is
induced. the faster ETC regresses hut also the more
hkelv se\ crc temporal hx percalcemiani des elop
In retrospect. the worsened hvpercalcemia in our case
after total parathyroidectom and introduction of low
calcium—dialvsate max he due to the same mechanism.
although so e did not obsero e any appreciable decrease
in the size of ETC during the course.
To our knowledge. our case is the first report in the
English literature to describe post-excisional improve
ment of hpercalcemia in ETC. Medications cannot
explain this change. because calcium—containing
medications and vitamin F) so crc discontinued during
the hospitalitation prior to surgery, vet hvpercalce—
inia persisted. In contrast, her serum calcium fell
signiticantlx afler the debulking. We cannot exclude
other possibilities for this drop. ‘itch as decreased oral
intake posh iperatively resulting in lower calcium and
phosphorus intake, Mitigating against this possibil
ity is the fact that her serum albumin levels had been
stable postoperatively.
Treatment of UTC is not established Six cases
of successt ul medical treatments so ith complete or
Fiaj arathyroidectomy,
-
2 UTC Discovered] -
_1 /1
V I
z’ A ‘.. 5.
7
‘/
I /
—zz- - Staw Lower Ca-contained
, Dialysatete (Ca 2 OmEq!L,
Oct Ci - 0i 2
Fi a ow a ‘0 a r rum in r i C
of vai b w r in in I II win in in d
IN II c I r I Ii 4Di d p ilfi slk:n
P.
124
significant rctsi’ession of L’TC have been reporte&- ‘ In these
eases, combined modalities were used to induce a neoatie CaxP
balance d.c. extended diaI sis time. includin2 daily nocturnal home
hemodial sis. use ol Inch-performance membrane dialvzers. use of
low calcium dialvsate in most cases. Recression of L’TC has also
been reported in those ss ho receis ed renal transplants
. \one
of these cases has reported recun’ence of k’TC or treatment-related
morh di t or mortal i t\ after i he i’ecression Thus, treatment ‘a ith the
aho\ e calcium—reduction reonnens appears to be sale and durable
es en thouch reported ii uinhers are small.
In summar
. [IC. althoueh rare, is one of the potentially life—
threatening complications of lon—tcrm dialysis. The prevalence
is apparently increasine. This may he related to recent therapeutic
modalities causine positive calcium balance. UTC itself may cause
hypercalcemia independent of parathyroid hormone. Given its
likely progression to a debilitating condition, aggressive medical
treatment targeting negative calcium balance is recommended before
contemplating surger. particularly when the UTC is too large for
complete excision.
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.Jucted here in Hawai’i that will
tv ofvour patient’s care.
J trials appl the latest medical
)rlnation to develop interventions that
[1 hec ime tomorrows standard.
Clinical trials cover the continuum of
patient care, not just treatments—fri )in
“Vuntion to tollow—up, and support.
• Hawai’i insurers, including Medicare and HMSA, will coi
the costs ofclinical trials.
• The latest most acuirate information on clinical trials, jfl
Hawai’i or around the orid, i’ in ailable b contaotin the
National Cancer IflstitMtL’s Cancet Intormation Sers ice it
1 800 4 CANCER, on the web at n.s,anccr.so.
Nowyou know.
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